News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Acticor Biotech has made a deal with Merck KGaA’s CMO MilliporeSigma to use its Provantage End-to-End services to make its anti-thrombotic antibody fragment ACT-017 for stroke.
Sanofi, Merck & Co. and downstream technology firm Natrix have teamed to develop a chromatography system with a productivity level capable to enable a fully-integrated downstream platform.
Sanofi and JHL Biotech will sell biosimilars in markets outside China in the long term according to the French drug firm.